sup plemental figures and figure le egends · ing for trab tion of oste enitor cells y facs...
TRANSCRIPT
Sup
Sup
(A)
1-m
qPC
MS
CD3
by F
pplemental
pplemental
Co-localiz
month-old b
CR detectio
C FACS em
31‐Ter119
FACS in BM
figures and
Figure S1.
zation of F
one marrow
on of Foxp1
mploying e
‐CD29+Sca
M from 1 an
d Figure le
. Expressio
Foxp1 and
w (BM). (B
1A, B, C, a
expression (
a1+. (D) qP
nd 18- mont
1
egends
n of Foxp1
d Nestin in
B) Location
and D isofo
(+) or abse
PCR detectio
ths-old dono
1 during M
n cultures
ns of oligon
forms. (C) R
ence (-) of
on of Foxp
ors.
SC differen
of MSCs
nucleotide p
Representat
standard m
1 and p16 i
ntiation.
isolated f
probes used
tive dot plo
markers: CD
in MSCs so
from
d for
ot of
D45‐
orted
Sup
(A,
qPC
loss
and
The
trab
of t
BV/
bon
Cb.T
pplemental
B) Assessm
CR and west
s of volume
BMD of co
e volume,
becular sepa
trabecular b
/TV, bone v
ne number;
Th., cortica
Figure S2.
ment of Fox
tern blotting
e, number, a
ortical bone
number an
aration was
bones and p
volume/tiss
Tb.Sp., trab
al bone thick
. Bone prop
xp1 express
g. **, P<0.0
and BMD o
es in Foxp1P
nd BMD o
increased in
parameters o
ue volume;
becular bon
kness. *indi
2
perties of F
sion in BM
01; n=4. (C
of trabecula
Prx1Δ/Δ mutan
of trabecul
n mutants a
of cortical b
; BMD, bon
ne separatio
icates P<0.0
Foxp1Prx1Δ/Δ
M MSCs from
C, D) μCT an
ar bones as
nts between
lar bones
as compared
bones were
ne mineral
on; Tb.Th.,
05; **, P<0
female mu
m Foxp1Prx
nalyses dete
well as volu
n 6 and 16 m
were decre
d to controls
e unaltered.
density; Tb
trabecular b
.01; ***, P<
utants.
x1Δ/Δ mutant
ects progres
lume, thickn
months. n=4
eased, whe
s. The thick
Abbreviati
b.N., trabec
bone thickn
<0.001; n=4
ts by
ssive
ness,
4. (E)
ereas
kness
ions:
cular
ness;
4.
Sup
(A)
(B)
oste
as
CD3
num
pplemental
TRAP stain
Quantifica
eoclast prog
defined b
3-B220-CD
mbers in (C)
Figure S3.
ning for trab
ation of oste
genitor cells
by FACS
11b-CSF1R
); ns, nonsig
. TRAP stai
becular bon
eoclast num
s in BM Fo
expression
R+cKit+ . (D
gnificant; n=
3
ining for os
nes of Foxp
mbers in (A
oxp1 mutant
(+) or
D) Quantifi
=3.
steoclasts i
1 mutant an
A). (C) Dot
t and contro
absence (-
fication of
n Foxp1Prx1
nd control m
plot of FA
ol mice at 3
-) of stan
osteoclast
1Δ/Δ mice.
mice at 3 of
ACS analysi
3 months of
ndard mark
progenitor
f age.
is of
f age
kers:
cell
Sup
oste
(A)
(pM
cult
adip
ALP
anal
MS
RT-
Sup
mic
pplemental
eoblasts in
Foxp1 w
MSCV-Foxp
tured in dif
pogenic ind
P staining. (
lyzed by R
Cs cells. (
qPCR follo
pplemental
ce.
Figure S4
MSCs.
was overex
1) followed
fferentiation
duction by o
(B) The exp
RT-qPCR 6
(C) Expres
owing 14 da
Figure S5.
4. Foxp1 re
pressed in
d by stable
n medium.
oil red O st
pression of a
days follow
sion of bo
ys of osteog
. Histologic
4
egulates th
n murine M
e-transfectio
Cell differ
taining or 1
adipogenic
wing adipo
one markers
genic cultur
cal analysis
he different
MSCs by
on of MSC
rentiation w
14 days afte
markers (C
genic induc
s (Alp and
re. *, P<0.0
s of the bon
tiation of a
insertion
Cs and the
was assesse
er osteogen
CEBP, PPA
ction of Fo
d Col1a1) a
5; ***, P<0
ne marrow
adipocytes
into retrov
en selected
ed 6 days
nic induction
AR and Fa
oxp1-expres
as assessed
0.001; n=3.
w in Foxp1N
and
virus
and
after
n by
bp4)
ssing
d by
NesΔ/Δ
5
(A) Growth curve of Foxp1NesΔ/Δ mice from measured at days after passage (P) from
P3 to P21. (B) H&E staining of tibias from Foxp1fl/fl and Foxp1NesΔ/Δ mice at P21.
Representative images were taken from the primary ossification region below the
growth plates. (C) Oil red O staining of the tibias of (B) at P21. Representative
images were taken from the secondary ossification proximal to the knee joint. (D)
Quantification of the adipose droplets in (C); ***, P<0.001; n=5.
Sup
in F
(A)
pplemental
Foxp1NesΔ/Δ
Represen
Figure S6.
mice.
ntative ima
. The altere
ages of F
6
ed osteogen
Foxp1NesΔ/Δ
nic and adip
and Foxp
pogenic po
p1fl/fl mice
otency of M
at P25.
MSCs
(B)
Rep
Foxp
BV/
rela
decr
P<0
asse
Oste
stain
adip
***
BM
Sup
(A)
mut
dete
BV/
bon
presentative
xp1NesΔ/Δ at
/TV, BMD
atively incre
reased but c
0.001; n=5.
essed 14 da
eogenic dif
ning at 21 d
pocyte colo
, P<0.001;
M mesenchym
pplemental
Representa
tant and Fo
ect no chan
/TV, bone v
ne number; T
images of
P21. (C) Q
D, Tb.N, T
eased. Simi
cortical BM
(D) The a
ays after a
fferentiation
days of diff
onies (CFU-
n=4. (G) W
mal progeni
Figure S7.
ative image
oxp1fl/fl cont
nges in bon
volume/tissu
Tb. Sp., trab
μCT analy
Quantificati
Tb.Th and
ilarly, Cb.T
MD was not
adipogenic
dipogenic i
n of mesenc
ferentiation
-Ad) and o
Western blot
itors from F
. Bone phen
s of trabecu
trol 3 month
ne propertie
ue volume;
becular bon7
ysis for trab
ion of bone
Tb.Sp we
Th and CV/
significantl
potency of
induction b
chymal prog
induction (
steoblast co
identificati
Foxp1NesΔ/Δ
notypes in
ular and cor
hs old mice
es in Foxp
BMD, bon
ne separatio
becular and
e properties
re decrease
/TV of the
ly altered. *
f BM mese
by oil red
genitors wa
lower panel
olonies (CF
on of PPAR
and Foxp1f
the Foxp1C
rtical bones
e by μCT a
p1Col2Δ/Δ mu
ne mineral
on; Tb. Th.,
cortical bo
indicating
ed, wherea
cortical bo
, P<0.05; *
enchymal p
O staining
as assessed
l). (E, F) Q
FU-Ob) in (
Rγ and Fabp
fl/fl mice at P
Col2Δ/Δ mice.
from tibia
nalyses. (B
utant mice.
density; Tb
trabecular
ones of tibia
that trabec
as BS/BV
ones were
**, P<0.01;
progenitors
(upper pa
by Alizarin
Quantificatio
(D). *, P<0
p4 expressio
P21.
.
of Foxp1Co
B) μCT anal
Abbreviati
b. N., trabec
bone thickn
as in
cular
was
also
***,
was
nel).
n red
on of
0.05;
on in
ol2Δ/Δ
lyses
ions:
cular
ness;
Cb.
Safr
at 8
mes
Sup
CEB
(A)
P<0
RBP
RBP
Th., cortic
ranin O stai
8 months of
senchymal p
pplemental
BP.
Foxp1 rep
0.01; ***, P
Pjκ in the n
Pjκ-Flag ex
cal bone th
ining of the
f age. (D) A
progenitor c
Figure S8
pressed the
P<0.001; n=
nuclei of C3
xpression v
hickness. *,
e growth pla
Alcian blue
cells after 14
8. Foxp1 re
transactiva
=3. (B) Co
H10T1/2 ce
vectors. G8
, P<0.05; *
ate of Foxp
e staining fo
4 days indu
epresses th
ation of PPA
o-localizatio
ells transfec
Green, anti-
**, P<0.01
p1Prx1Δ/Δ mu
or the chon
uction.
he transacti
PAR-Luc by
on of Foxp1
cted with Fo
Flag; red,
; ***, P<0
utant and Fo
drogenic di
ivation of P
y CEBP.
1 with CEB
oxp1 and CE
anti-Foxp1
0.001; n=5.
oxp1fl/fl con
ifferentiatio
PPAR-Luc
*, P<0.05;
BPβ, CEBP
EBPβ/δ-Fla
1; blue, D
(C)
ntrols
on of
c by
; **,
Pδ or
ag or
DAPI
9
staining to identify nuclei. Bar, 50 μm. (C) Schematic diagram showing that the
mutation induced within the p16 promoter, which was employed in Figure 6C. (D)
Representative histograms of DCFDA mean fluorescence intensities in mesenchymal
progenitors of the second passages of cultures. (E) Expression of FOXP1 in P1, P3
and P5 passages of 27- and 74-year-old hMPCs following Foxp1 lentiviral-mediated
overexpression.
Oligos sequence for PCR
Primers for realtime PCR Species Name Sequence
Mouse
β-actin-F AGAGGGAAATCGTGCGTGACA β-actin-R CACTGTGTTGGCATAGAGGTC Foxp1-F TCTCGTCCTCGGCACCTT Foxp1-R GTCACAAACCGCCTCACA Nestin-F CACACCTCAAGATGTCCC Nestin-R GAAAGCCAAGAGAAGCCT Cebpα-F TGGACAAGAACAGCAACGAG Cebpα-R TCACTGGTCAACTCCAGCAC PPARγ-F GGAAAGACAACGGACAAATCAC PPARγ-R TACGGATCGAAACTGGCAC Fabp4-F GATGAAATCACCGCAGACGACA Fabp4-R ATTGTGGTCGACTTTCCATCCC p21-F GAACATCTCAGGGCCGAAAAC p21-R CTGCGCTTGGAGTGATAGAA p27-F ACTAACCCGGGACTTGGAGA P27-R GAAATTCCACTTGCGCTGAC p53-F GTCACAGCACATGACGGAGG p53-R TCTTCCAGATACTCGGGATAC p16-F CTAGAGAGGATCTTGAGAAGAGGGC p16-R TAGTTGAGCAGAAGAGCTGCTACGT Bmi-F CTACACGCTAATGGACATTGCCT Bmi-R CCATCCCTCTGGTGACTCATCTT Hey1-F CACTGCAGGAGGGAAAGGTTAT Hey1-R CCCCAAACTCCGATAGTCCAT HeyL-F GAAGCGCAGAGGGATCATAGA HeyL-R CCAATCGTCGCAATTCAGAA Jagged1-F CTTCAATCTCAAGGCCAGCC Jagged1-R CAGGCGAAACTGAAAGGCAG
10
Alp-F GCCTGGATCTCATCAGTATTTGG Alp-R GTTCAGTGCGGTTCCAGACAT Col1α1-F CCGGAAGAATACGTATCACC Col1α1-R ACCAGGAGGACCAGGAAGTC Runx2-F CCGGGAATGATGAGAACTA Runx2-R ACCGTCCACTGTCACTTT Osterix-F CTCTCTGCTTGAGGAAGAAG Osterix-R GTCCATTGGTGCTTGAGAAG
Human
ALP-F AACATCAGGGACATTGACGTG ALP-R GTATCTCGGTTTGAAGCTCTTCC COL1A1-F GTGCGATGACGTGATCTGTGA COL1A1-R CGGTGGTTTCTTGGTCGGT HEY1-F ATCTGCTAAGCTAGAAAAAGCCG HEY1-R GTGCGCGTCAAAGTAACCT HEYL-F GGAAGAAACGCAGAGGGATCA HEYL-R CAAGCGTCGCAATTCAGAAAG ACTIN-F CCAGCACAATGAAGATCAAGAT ACTIN-R AGAAAGGGTGTAACGCAACTAA FOXP1-F GGGGCAGTATGGACAGTGGATGA FOXP1-R TTGAGAGGTGTGCAGTAGGCGTG
Primers for ChIP-PCR
Name Sequence Pparg-ChIP-F CCCATTGAGCTATTGCTTC Pparg-ChIP-R TCAGTGACTTGTGGACTTT p16-ChIP-F TACACAGTTATGAGTTAGGGCAAp16-ChIP-R CTTCTTGAGGTCTGTAAGGAAAA
Figure 1B
Foxp1
β-actin
1M 8M 30M
β-actin
Foxp1
26 27 33 41 74 75 82M
Figure 1E
Figure 2B
Foxp1
β-actin
Foxp1 Pr
x1Δ/Δ
Foxp
1fl/fl
Figure 4F
PPARγ
β-actin
Fabp4
Foxp1 Pr
x1Δ/Δ
Foxp
1fl/fl
Foxp1 Pr
x1Δ/Δ
Foxp
1fl/fl
Figure 4A Figure 4B
- + ++ - +
- + ++ - +
Cebpβ-Flag
Foxp1-His
Input Output
IP-His IB-Flag
IP-FlagIB-His
- + ++ - +
- + ++ - +
Cebpδ-Flag
Foxp1-His
Input Output
Figure 4C Figure 4J
Figure 4K
Foxp1
Cebpβ
Cebpδ
Rbpjk
- + ++ - +
- + ++ - +
Rbpjk-Flag
Foxp1-His
IP-HisIB-Flag
IP-FlagIB-His
Input IgG anti-Foxp1
Input Output
Foxp1
Figure 5G
Foxp1
LAP2ββ-actinH3K9me3
p16
Foxp1 Pr
x1Δ/Δ
Foxp
1fl/fl
Foxp1 Pr
x1Δ/Δ
Foxp
1fl/fl
Foxp1 Pr
x1Δ/Δ
Foxp
1fl/fl
Foxp1 Pr
x1Δ/Δ
Foxp
1fl/fl Foxp1 Pr
x1Δ/Δ
Foxp
1fl/fl
β-actin
Foxp1 Pr
x1Δ/Δ
Foxp
1fl/fl
Figure 7H
FABP4
β-ACTIN
PPARγ
LV-G
FP
LV-FO
XP1
Foxp1 ne
sΔ/Δ
Foxp
1fl/fl
PPARγ
Fabp4
β-actin
Figure S6G